Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.00-1.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.29M | -3.39M | -4.44M | -6.45M | -3.50M |
| Total Depreciation and Amortization | 29.00K | 19.00K | 21.00K | 22.00K | 23.00K |
| Total Amortization of Deferred Charges | 445.00K | 372.00K | 313.00K | 708.00K | 1.35M |
| Total Other Non-Cash Items | -383.00K | -3.12M | -553.00K | -763.00K | -1.76M |
| Change in Net Operating Assets | 5.32M | 3.98M | 2.51M | 4.20M | 2.29M |
| Cash from Operations | -1.88M | -2.14M | -2.15M | -2.29M | -1.59M |
| Capital Expenditure | -7.00K | -6.00K | -8.00K | -12.00K | -12.00K |
| Sale of Property, Plant, and Equipment | 4.00K | 4.00K | 4.00K | 4.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.17M | 2.17M | 2.51M | 2.51M | 2.51M |
| Cash from Investing | 2.17M | 2.17M | 2.50M | 2.50M | 2.50M |
| Total Debt Issued | 5.47M | 4.95M | 3.92M | 4.11M | 5.25M |
| Total Debt Repaid | -6.73M | -5.64M | -4.66M | -5.46M | -6.41M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.26M | -694.00K | -743.00K | -1.35M | -1.16M |
| Foreign Exchange rate Adjustments | 4.00K | 22.00K | 7.00K | -19.00K | 10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -962.00K | -640.00K | -379.00K | -1.16M | -250.00K |